On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Functional imaging has many potential uses in cancer: as a predictive biomarker, for directing radiotherapy or targeted systemic therapy and in assessment of response. However, these have to date found limited use clinically. The investigation of both established imaging methods (perfusion CT and MRI, FMISO- and FDG-PET) and novel functional imaging techniques (CEST and oxygen-enhanced MRI) through longitudinal imaging studies of patients undergoing radiotherapy will be presented. Comparison with histopathological assessment and the potential to combine imaging with genetic data to provide a tailored management plan for patients with cancer will be discussed
